These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12235080)

  • 1. Pk11195, a mitochondrial benzodiazepine receptor antagonist, reduces apoptosis threshold in Bcl-X(L) and Mcl-1 expressing human cholangiocarcinoma cells.
    Okaro AC; Fennell DA; Corbo M; Davidson BR; Cotter FE
    Gut; 2002 Oct; 51(4):556-61. PubMed ID: 12235080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PK11195, a ligand of the mitochondrial benzodiazepine receptor, facilitates the induction of apoptosis and reverses Bcl-2-mediated cytoprotection.
    Hirsch T; Decaudin D; Susin SA; Marchetti P; Larochette N; Resche-Rigon M; Kroemer G
    Exp Cell Res; 1998 Jun; 241(2):426-34. PubMed ID: 9637784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mcl-1 mediates tumor necrosis factor-related apoptosis-inducing ligand resistance in human cholangiocarcinoma cells.
    Taniai M; Grambihler A; Higuchi H; Werneburg N; Bronk SF; Farrugia DJ; Kaufmann SH; Gores GJ
    Cancer Res; 2004 May; 64(10):3517-24. PubMed ID: 15150106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility of cholangiocarcinoma cells to parthenolide-induced apoptosis.
    Kim JH; Liu L; Lee SO; Kim YT; You KR; Kim DG
    Cancer Res; 2005 Jul; 65(14):6312-20. PubMed ID: 16024633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression of antiapoptotic proteins Bcl-2, Bcl-X(L), and Mcl-1 in benign, dysplastic, and malignant biliary epithelium.
    Okaro AC; Deery AR; Hutchins RR; Davidson BR
    J Clin Pathol; 2001 Dec; 54(12):927-32. PubMed ID: 11729212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of Bcl-2-mediated resistance of the EW36 human B-cell lymphoma cell line to arsenite- and pesticide-induced apoptosis by PK11195, a ligand of the mitochondrial benzodiazepine receptor.
    Muscarella DE; O'Brien KA; Lemley AT; Bloom SE
    Toxicol Sci; 2003 Jul; 74(1):66-73. PubMed ID: 12730627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABT737 enhances cholangiocarcinoma sensitivity to cisplatin through regulation of mitochondrial dynamics.
    Fan Z; Yu H; Cui N; Kong X; Liu X; Chang Y; Wu Y; Sun L; Wang G
    Exp Cell Res; 2015 Jul; 335(1):68-81. PubMed ID: 25936772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Celecoxib-induced apoptosis in rat cholangiocarcinoma cells mediated by Akt inactivation and Bax translocation.
    Zhang Z; Lai GH; Sirica AE
    Hepatology; 2004 Apr; 39(4):1028-37. PubMed ID: 15057907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis of human cholangiocarcinoma cell lines induced by β-escin through mitochondrial caspase-dependent pathway.
    Shen DY; Kang JH; Song W; Zhang WQ; Li WG; Zhao Y; Chen QX
    Phytother Res; 2011 Oct; 25(10):1519-26. PubMed ID: 21394804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bcl-x
    Hoffmeister-Wittmann P; Mock A; Nichetti F; Korell F; Heilig CE; Scherr AL; Günther M; Albrecht T; Kelmendi E; Xu K; Nader L; Kessler A; Schmitt N; Fritzsche S; Weiler S; Sobol B; Stenzinger A; Boeck S; Westphalen CB; Schulze-Osthoff K; Trojan J; Kindler T; Weichert W; Spiekermann K; Bitzer M; Folprecht G; Illert AL; Boerries M; Klauschen F; Ochsenreither S; Siveke J; Bauer S; Glimm H; Brors B; Hüllein J; Hübschmann D; Uhrig S; Horak P; Kreutzfeldt S; Banales JM; Springfeld C; Jäger D; Schirmacher P; Roessler S; Ormanns S; Goeppert B; Fröhling S; Köhler BC
    Liver Int; 2022 Dec; 42(12):2855-2870. PubMed ID: 35983950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo suppression of Bcl-XL expression facilitates chemotherapy-induced leukaemia cell death in a SCID/NOD-Hu model.
    Fennell DA; Corbo MV; Dean NM; Monia BP; Cotter FE
    Br J Haematol; 2001 Mar; 112(3):706-13. PubMed ID: 11260076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The peripheral benzodiazepine receptor ligand PK11195 overcomes different resistance mechanisms to sensitize AML cells to gemtuzumab ozogamicin.
    Walter RB; Raden BW; Cronk MR; Bernstein ID; Appelbaum FR; Banker DE
    Blood; 2004 Jun; 103(11):4276-84. PubMed ID: 14962898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tamoxifen (TMX)/Fas induced growth inhibition of human cholangiocarcinoma (HCC) by gamma interferon (IFN-gamma).
    Vickers SM; Jhala NC; Ahn EY; McDonald JM; Pan G; Bland KI
    Ann Surg; 2002 Jun; 235(6):872-8. PubMed ID: 12035045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting BCL-2 family proteins to overcome drug resistance in non-small cell lung cancer.
    Wesarg E; Hoffarth S; Wiewrodt R; Kröll M; Biesterfeld S; Huber C; Schuler M
    Int J Cancer; 2007 Dec; 121(11):2387-94. PubMed ID: 17688235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ZD1839 (IRESSA) stabilizes p27Kip1 and enhances radiosensitivity in cholangiocarcinoma cell lines.
    Yabuuchi S; Katayose Y; Oda A; Mizuma M; Shirasou S; Sasaki T; Yamamoto K; Oikawa M; Rikiyama T; Onogawa T; Yoshida H; Ohtuska H; Motoi F; Egawa S; Unno M
    Anticancer Res; 2009 Apr; 29(4):1169-80. PubMed ID: 19414361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin 6 upregulates myeloid cell leukemia-1 expression through a STAT3 pathway in cholangiocarcinoma cells.
    Isomoto H; Kobayashi S; Werneburg NW; Bronk SF; Guicciardi ME; Frank DA; Gores GJ
    Hepatology; 2005 Dec; 42(6):1329-38. PubMed ID: 16317687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cooperative cytotoxicity of proteasome inhibitors and tumor necrosis factor-related apoptosis-inducing ligand in chemoresistant Bcl-2-overexpressing cells.
    Nencioni A; Wille L; Dal Bello G; Boy D; Cirmena G; Wesselborg S; Belka C; Brossart P; Patrone F; Ballestrero A
    Clin Cancer Res; 2005 Jun; 11(11):4259-65. PubMed ID: 15930365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bcl-x(L) and Myeloid cell leukaemia-1 contribute to apoptosis resistance of colorectal cancer cells.
    Schulze-Bergkamen H; Ehrenberg R; Hickmann L; Vick B; Urbanik T; Schimanski CC; Berger MR; Schad A; Weber A; Heeger S; Galle PR; Moehler M
    World J Gastroenterol; 2008 Jun; 14(24):3829-40. PubMed ID: 18609706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Over-expression of interleukin-6 enhances cell survival and transformed cell growth in human malignant cholangiocytes.
    Meng F; Yamagiwa Y; Ueno Y; Patel T
    J Hepatol; 2006 Jun; 44(6):1055-65. PubMed ID: 16469407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bcl-2 degradation is an additional pro-apoptotic effect of polo-like kinase inhibition in cholangiocarcinoma cells.
    Sydor S; Jafoui S; Wingerter L; Swoboda S; Mertens JC; Gerken G; Canbay A; Paul A; Fingas CD
    World J Gastroenterol; 2017 Jun; 23(22):4007-4015. PubMed ID: 28652654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.